Health ministry recommends remdesivir for moderate cases, HCQ for early course of COVID-19
Posted by
www.biotecnika.org
Under emergency use authorization, remdesivir may be considered for
patients in moderate stage requiring oxygen support. It is not
recommended for those with severe renal impairment and high level of
liver enzymes, pregnant and lactating women, and those below 12 years,
the document stated.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/health-ministry-recommends-remdesivir-for-moderate-cases-hcq-for-early-course-of-covid-19/articleshow/76360119.cms
Subscribe to:
Post Comments (Atom)
Post a Comment